tetano
Editor, Senior Moderator
Commun Biol
. 2022 Mar 22;5(1):249.
doi: 10.1038/s42003-022-03204-3.
Influenza A virus diffusion through mucus gel networks
Logan Kaler[SUP] 1 [/SUP], Ethan Iverson[SUP] 2 [/SUP], Shahed Bader[SUP] 3 [/SUP], Daniel Song[SUP] 3 [/SUP], Margaret A Scull[SUP] 2 [/SUP], Gregg A Duncan[SUP] 4 5 [/SUP]
Affiliations
Abstract
Mucus in the lung plays an essential role as a barrier to infection by viral pathogens such as influenza A virus (IAV). Previous work determined mucin-associated sialic acid acts as a decoy receptor for IAV hemagglutinin (HA) binding and the sialic-acid cleaving enzyme, neuraminidase (NA), facilitates virus passage through mucus. However, it has yet to be fully addressed how the physical structure of the mucus gel influences its barrier function and its ability to trap viruses via glycan mediated interactions to prevent infection. To address this, IAV and nanoparticle diffusion in human airway mucus and mucin-based hydrogels is quantified using fluorescence video microscopy. We find the mobility of IAV in mucus is significantly influenced by the mesh structure of the gel and in contrast to prior reports, these effects likely influence virus passage through mucus gels to a greater extent than HA and NA activity. In addition, an analytical approach is developed to estimate the binding affinity of IAV to the mucus meshwork, yielding dissociation constants in the mM range, indicative of weak IAV-mucus binding. Our results provide important insights on how the adhesive and physical barrier properties of mucus influence the dissemination of IAV within the lung microenvironment.
. 2022 Mar 22;5(1):249.
doi: 10.1038/s42003-022-03204-3.
Influenza A virus diffusion through mucus gel networks
Logan Kaler[SUP] 1 [/SUP], Ethan Iverson[SUP] 2 [/SUP], Shahed Bader[SUP] 3 [/SUP], Daniel Song[SUP] 3 [/SUP], Margaret A Scull[SUP] 2 [/SUP], Gregg A Duncan[SUP] 4 5 [/SUP]
Affiliations
- PMID: 35318436
- DOI: 10.1038/s42003-022-03204-3
Abstract
Mucus in the lung plays an essential role as a barrier to infection by viral pathogens such as influenza A virus (IAV). Previous work determined mucin-associated sialic acid acts as a decoy receptor for IAV hemagglutinin (HA) binding and the sialic-acid cleaving enzyme, neuraminidase (NA), facilitates virus passage through mucus. However, it has yet to be fully addressed how the physical structure of the mucus gel influences its barrier function and its ability to trap viruses via glycan mediated interactions to prevent infection. To address this, IAV and nanoparticle diffusion in human airway mucus and mucin-based hydrogels is quantified using fluorescence video microscopy. We find the mobility of IAV in mucus is significantly influenced by the mesh structure of the gel and in contrast to prior reports, these effects likely influence virus passage through mucus gels to a greater extent than HA and NA activity. In addition, an analytical approach is developed to estimate the binding affinity of IAV to the mucus meshwork, yielding dissociation constants in the mM range, indicative of weak IAV-mucus binding. Our results provide important insights on how the adhesive and physical barrier properties of mucus influence the dissemination of IAV within the lung microenvironment.
